EMA Application withdrawn: Synordia (fenofibrate;metformin) — Fournier Laboratories Ireland Ltd.

View source ↗

Summary

The EMA withdrew the application for Synordia (fenofibrate; metformin) from Fournier Laboratories Ireland Ltd. for Diabetes Type 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Synordia

Snippet

Status: Application withdrawn. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Fournier Laboratories Ireland Ltd.. Decision date: 31/12/2009